Zobrazeno 1 - 10
of 163
pro vyhledávání: '"C, Canosa"'
Autor:
A. Gasol Cudós, S. Morales Murillo, N. Tuset Der-Abrain, D.R. Sánchez Guzmán, F. Vilardell Villellas, E. Morera M orillo, C. Canosa Morales, J. Melé Olivé, L. Arbonés Cid
Publikováno v:
Breast, Vol 68, Iss , Pp S19- (2023)
Externí odkaz:
https://doaj.org/article/34c3d667b005454bad6eb76a6f3fcf67
Autor:
A. Gasol Cudos, S. Morales Murillo, O. Pallisé Subirats, A. Rodriguez Galindo, J. Veas Rodriguez, D.R. Sanchez Guzman, F. Vilardell Villellas, C. Canosa Morales, J. Melé Olivé, E. Iglesias Martinez
Publikováno v:
Breast, Vol 56, Iss , Pp S52-S53 (2021)
Externí odkaz:
https://doaj.org/article/ca0e28683e7541328275db88f0730bb2
Autor:
A. Serrate Lopez, A. Gasol Cudos, C. Canosa Morales, S. Morales Murillo, A. Velasco Sanchez, J. Melé Olivé, J Veas Rodriguez
Publikováno v:
Cancer Research. 79:P3-10
Background: Pathologic response to neoadjuvant therapy is the most important prognostic factor so new agents should aim to improve it. HER2 expression in breast cancer provides prognostic and predictive information of response to antiHER2 therapy. Th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e4d33bdb8d44843a448df10c1e23e28d
https://doi.org/10.1158/1538-7445.sabcs18-p3-10-17
https://doi.org/10.1158/1538-7445.sabcs18-p3-10-17
Autor:
J Veas Rodriguez, A. Velasco Sanchez, Susana Morales, J. Melé Olivé, C. Canosa Morales, A. Gasol Cudos, A. Serrate Lopez
Publikováno v:
Cancer Research. 79:P3-08
Background: Studies of mutational analysis have been widely reported in various global series of breast cancer. However, in the era of different phenotypes of breast cancer, these analyses should be more specific in order to find differences in each
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::04e200257b90121b65aa68590a138687
https://doi.org/10.1158/1538-7445.sabcs18-p3-08-24
https://doi.org/10.1158/1538-7445.sabcs18-p3-08-24
Autor:
S. Morales Murillo, A. Velasco Sanchez, J. Melé Olivé, O. Pallisé Subirats, D.R. Sanchez Guzman, A. Gasol Cudos, J.F. Cordoba Ortega, F. Vilardell Villellas, C. Canosa Morales
Publikováno v:
Annals of Oncology. 32:S437
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05d763e1c1fc1041b482d50d2c07df22
https://doi.org/10.1016/j.annonc.2021.08.461
https://doi.org/10.1016/j.annonc.2021.08.461
Autor:
C. Canosa Morales, A. Rodriguez Galindo, A. Gasol Cudos, Serafin Morales, J. Melé Olivé, A. Serrate Lopez, A. Velasco Sanchez
Publikováno v:
Annals of Oncology. 31:S333
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0f3a1c7bae02de563a102b3b80bcdb5b
https://doi.org/10.1016/j.annonc.2020.08.351
https://doi.org/10.1016/j.annonc.2020.08.351
Autor:
A. Gasol Cudos, A. Rodriguez Galindo, A. Serrate Lopez, A. Velasco Sanchez, J. Melé Olivé, C. Canosa Morales, Serafin Morales
Publikováno v:
Annals of Oncology. 31:S332
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f54c7ef8098cde5fc1bbded6f6938d9a
https://doi.org/10.1016/j.annonc.2020.08.349
https://doi.org/10.1016/j.annonc.2020.08.349
Autor:
Serafin Morales, A. Rodriguez Galindo, A. Velasco, J. Melé Olivé, C. Canosa Morales, D.R. Sanchez Guzman, A. Gasol Cudos
Publikováno v:
Annals of Oncology. 31:S51
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7e79c69a393f24a9a63d9793f3ece578
https://doi.org/10.1016/j.annonc.2020.03.042
https://doi.org/10.1016/j.annonc.2020.03.042
Autor:
J. Melé Olivé, A. Gasol Cudos, F. Vilardell Villellas, J Veas Rodriguez, C. Canosa Morales, E. Iglesias Martinez, I. el Koulali, D.R. Sanchez Guzman, S. Morales Murillo
Publikováno v:
Annals of Oncology. 30:v90
Background Nodal involvement is a common prognostic factor in early breast cancer (EBC) but their response and assessment after neoadjuvant chemotherapy (NAC) is controversial, hence its impact in survival is not clear. Methods We analyze a cohort of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94caca0008c4b38f5ba1efa8692df40a
https://doi.org/10.1093/annonc/mdz240.090
https://doi.org/10.1093/annonc/mdz240.090
Autor:
J. Melé Olivé, S. Morales Murillo, E. Iglesias Martinez, C. Canosa Morales, M I Gil García, J Veas Rodriguez, J.F. Cordoba Ortega, I. el Koulali, A. Gasol Cudos
Publikováno v:
Annals of Oncology. 30:v93
Background Patients with early breast cancer (EBC) achieving pathologic complete response (pCR) after neoadjuvant chemotherapy (NACT) have a favorable prognosis. Breast surgery and more chemotherapy treatment might be avoided in patients in whom the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8fdd7ed25f244f1a089bfc6b13ecec0e
https://doi.org/10.1093/annonc/mdz240.101
https://doi.org/10.1093/annonc/mdz240.101